Yestar Healthcare Holdings Company Limited (HKG:2393)
Hong Kong
· Delayed Price · Currency is HKD 0.0770
-0.0020 (-2.53%)
May 2, 2025, 3:35 PM HKT
HKG:2393 Revenue
In the year 2024, Yestar Healthcare Holdings Company had annual revenue of 2.41B CNY, down -17.26%. Yestar Healthcare Holdings Company had revenue of 1.14B in the half year ending December 31, 2024.
Revenue
2.41B CNY
Revenue Growth
-17.26%
P/S Ratio
0.07
Revenue / Employee
3.84M CNY
Employees
627
Market Cap
184.20M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.41B | -502.82M | -17.26% |
| Dec 31, 2023 | 2.91B | 108.21M | 3.86% |
| Dec 31, 2022 | 2.80B | -2.13B | -43.12% |
| Dec 31, 2021 | 4.93B | 823.75M | 20.06% |
| Dec 31, 2020 | 4.11B | -796.33M | -16.24% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Innovent Biologics | 10.03B |
| Alibaba Health Information Technology | 31.39B |
| Akeso | 2.26B |
| Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |